The global infectious disease in vitro diagnostics market size is expected to reach USD 28.05 billion by 2030, registering a CAGR of 2.4% during the forecast period. The rising prevalence of infectious diseases, such as tuberculosis & COVID-19, and technological advancements are projected to drive the product demand in the coming years. The rising prevalence of multi-drug resistant infections is enhancing the early diagnosis of infectious diseases. For instance, MDR infections are highly common in ICU patients, as per the Microbial Drug Resistance Journal in 2021, the prevalence of MDR infections in critically ill SARS-CoV-2 patients ranged between14% and 50%.
The delay in diagnosis and treatment with antibiotics before infection diagnosis is further escalating the prevalence of drug resistant-bacteria, creating a lucrative opportunity for industry growth. The industry is witnessing a significant number of product launches to meet the demands of consumers. For instance, in May 2022, BD introduced its automated diagnostic platform for infectious diseases in the U.S. The system allows the loading of 1700 specimens and the need for specimen sorting is also eliminated, thereby, reducing errors. Products offered by various competitors have been strategically priced to increase competitive rivalry.
However, complexity in buying behavior increases prominently when consumers have to choose between PoC and lab-based tests owing to differences in sensitivity and beliefs. The industry is oligopolistic with companies, such as Hoffmann-La Roche Ltd., Alere, bioMérieux, and BD, holding the majority of the share collectively. The global industry is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products. Competitive rivalry is estimated to increase during the forecast period owing to the expected launch of novel biomarker kits. Competitors are adopting key strategies, such as product launches and organizing awareness programs, to gain higher market shares.
This product will be delivered within 2 business days.
The delay in diagnosis and treatment with antibiotics before infection diagnosis is further escalating the prevalence of drug resistant-bacteria, creating a lucrative opportunity for industry growth. The industry is witnessing a significant number of product launches to meet the demands of consumers. For instance, in May 2022, BD introduced its automated diagnostic platform for infectious diseases in the U.S. The system allows the loading of 1700 specimens and the need for specimen sorting is also eliminated, thereby, reducing errors. Products offered by various competitors have been strategically priced to increase competitive rivalry.
However, complexity in buying behavior increases prominently when consumers have to choose between PoC and lab-based tests owing to differences in sensitivity and beliefs. The industry is oligopolistic with companies, such as Hoffmann-La Roche Ltd., Alere, bioMérieux, and BD, holding the majority of the share collectively. The global industry is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products. Competitive rivalry is estimated to increase during the forecast period owing to the expected launch of novel biomarker kits. Competitors are adopting key strategies, such as product launches and organizing awareness programs, to gain higher market shares.
Infectious Disease In Vitro Diagnostics Market Report Highlights
- The reagents product segment held the largest revenue share in 2023 owing to its high-volume usage in testing
- The molecular diagnostics segment held the largest share in 2023 owing to an increased number of product launches in the segment and increased adoption due to its high accuracy
- By application, the COVID-19 segment dominated the industry in 2023 due to the high expenditure on testing, to reduce the spread of the virus
- The central laboratories segment held the highest revenue share in 2023 due to the higher accuracy of laboratory-based tests, which makes them more reliable as compared to PoC and home tests, giving these tests a competitive edge over the other two segments
- North America dominated the global industry in 2023 due to its favorable regulatory framework, focus on preventive & early testing, and the higher adoption rate of novel diagnostics in this region.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
1.2. Market Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Infectious Disease In Vitro Diagnostics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Growing geriatric population
3.2.1.2. Technological advancements
3.2.1.3. High demand for PoC facilities
3.2.1.4. Increasing prevalence of infectious diseases
3.2.1.5. External funding for R&D activities
3.2.2. Market Restraints Analysis
3.2.2.1. High prices of IVD tests
3.3. Infectious Disease In Vitro Diagnostics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Growing geriatric population
3.2.1.2. Technological advancements
3.2.1.3. High demand for PoC facilities
3.2.1.4. Increasing prevalence of infectious diseases
3.2.1.5. External funding for R&D activities
3.2.2. Market Restraints Analysis
3.2.2.1. High prices of IVD tests
3.3. Infectious Disease In Vitro Diagnostics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
Chapter 4. Infectious Disease In Vitro Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Infectious Disease In Vitro Diagnostics Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Instruments
4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4. Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.5. Software
4.5.1. Software Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.2. Infectious Disease In Vitro Diagnostics Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Instruments
4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4. Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.5. Software
4.5.1. Software Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 5. Infectious Disease In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Infectious Disease In Vitro Diagnostics Market: Technology Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Immunoassay
5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.4. Molecular Diagnostics
5.4.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.5. Microbiology
5.5.1. Microbiology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.2. Infectious Disease In Vitro Diagnostics Market: Technology Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Immunoassay
5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.4. Molecular Diagnostics
5.4.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.5. Microbiology
5.5.1. Microbiology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 6. Infectious Disease In Vitro Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Infectious Disease In Vitro Diagnostics Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
6.3. MRSA
6.3.1. MRSA Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.4. Streptococcus
6.4.1. Streptococcus Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.5. Clostridium difficile
6.5.1. Clostridium difficile Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.6. VRE
6.6.1. VRE Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.7. CRE
6.7.1. CRE Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.8. Respiratory Virus
6.8.1. Respiratory Virus Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.9. Candida
6.9.1. Candida Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.10. TB and drug-resistant TB
6.10.1. TB and Drug-resistant TB Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.11. Gastro-intestinal panel testing
6.11.1. Gastro-intestinal Panel Testing Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.12. Chlamydia
6.12.1. Chlamydia Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.13. Gonorrhea
6.13.1. Gonorrhea Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.14. HPV
6.14.1. HPV Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.15. HIV
6.15.1. HIV Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.16. Hepatitis C
6.16.1. Hepatitis C Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.17. Hepatitis B
6.17.1. Hepatitis B Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.18. COVID-19
6.18.1. COVID-19 Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.19. Other Infectious Diseases
6.19.1. Others Market Revenue Estimates and Forecasts, 2018 -
6.2. Infectious Disease In Vitro Diagnostics Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
6.3. MRSA
6.3.1. MRSA Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.4. Streptococcus
6.4.1. Streptococcus Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.5. Clostridium difficile
6.5.1. Clostridium difficile Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.6. VRE
6.6.1. VRE Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.7. CRE
6.7.1. CRE Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.8. Respiratory Virus
6.8.1. Respiratory Virus Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.9. Candida
6.9.1. Candida Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.10. TB and drug-resistant TB
6.10.1. TB and Drug-resistant TB Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.11. Gastro-intestinal panel testing
6.11.1. Gastro-intestinal Panel Testing Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.12. Chlamydia
6.12.1. Chlamydia Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.13. Gonorrhea
6.13.1. Gonorrhea Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.14. HPV
6.14.1. HPV Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.15. HIV
6.15.1. HIV Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.16. Hepatitis C
6.16.1. Hepatitis C Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.17. Hepatitis B
6.17.1. Hepatitis B Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.18. COVID-19
6.18.1. COVID-19 Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.19. Other Infectious Diseases
6.19.1. Others Market Revenue Estimates and Forecasts, 2018 -
Chapter 7. Infectious Disease In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Infectious Disease In Vitro Diagnostics Market: Test Location Movement Analysis, 2023 & 2030 (USD Billion)
7.3. Point of Care
7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.4. Central Laboratories
7.4.1. Central Laboratories Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.2. Infectious Disease In Vitro Diagnostics Market: Test Location Movement Analysis, 2023 & 2030 (USD Billion)
7.3. Point of Care
7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.4. Central Laboratories
7.4.1. Central Laboratories Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 8. Infectious Disease In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Infectious Disease In Vitro Diagnostics Market Share, By Region, 2023 & 2030 (USD Billion)
8.2. North America
8.2.1. North America Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Regulatory Landscape/Reimbursement Scenario
8.2.2.3. Competitive Insights
8.2.2.4. U.S. Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Regulatory Landscape/Reimbursement Scenario
8.2.3.3. Competitive Insights
8.2.3.4. Canada Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3. Europe
8.3.1. Europe Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.2. U.K.
8.3.2.1. Key Country Dynamics
8.3.2.2. Regulatory Landscape/Reimbursement Scenario
8.3.2.3. Competitive Insights
8.3.2.4. U.K. Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Regulatory Landscape/Reimbursement Scenario
8.3.3.3. Competitive Insights
8.3.3.4. Germany Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Regulatory Landscape/Reimbursement Scenario
8.3.4.3. Competitive Insights
8.3.4.4. France Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Regulatory Landscape/Reimbursement Scenario
8.3.5.3. Competitive Insights
8.3.5.4. Italy Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Regulatory Landscape/Reimbursement Scenario
8.3.6.3. Competitive Insights
8.3.6.4. Spain Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.7. Sweden
8.3.7.1. Key Country Dynamics
8.3.7.2. Regulatory Landscape/Reimbursement Scenario
8.3.7.3. Competitive Insights
8.3.7.4. Sweden Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.8. Denmark
8.3.8.1. Key Country Dynamics
8.3.8.2. Regulatory Landscape/Reimbursement Scenario
8.3.8.3. Competitive Insights
8.3.8.4. Denmark Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Regulatory Landscape/Reimbursement Scenario
8.3.9.3. Competitive Insights
8.3.9.4. Norway Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.2. China
8.4.2.1. Key Country Dynamics
8.4.2.2. Regulatory Landscape/Reimbursement Scenario
8.4.2.3. Competitive Insights
8.4.2.4. China Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.3. Japan
8.4.3.1. Key Country Dynamics
8.4.3.2. Regulatory Landscape/Reimbursement Scenario
8.4.3.3. Competitive Insights
8.4.3.4. Japan Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Regulatory Landscape/Reimbursement Scenario
8.4.4.3. Competitive Insights
8.4.4.4. India Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Regulatory Landscape/Reimbursement Scenario
8.4.5.3. Competitive Insights
8.4.5.4. South Korea Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Regulatory Landscape/Reimbursement Scenario
8.4.6.3. Competitive Insights
8.4.6.4. Australia Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Regulatory Landscape/Reimbursement Scenario
8.4.7.3. Competitive Insights
8.4.7.4. Thailand Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.5. Latin America
8.5.1. Latin America Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Regulatory Landscape/Reimbursement Scenario
8.5.2.3. Competitive Insights
8.5.2.4. Brazil Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Regulatory Landscape/Reimbursement Scenario
8.5.3.3. Competitive Insights
8.5.3.4. Mexico Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Regulatory Landscape/Reimbursement Scenario
8.5.4.3. Competitive Insights
8.5.4.4. Argentina Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.6.2. Saudi Arabia
8.6.2.1. Key Country Dynamics
8.6.2.2. Regulatory Landscape/Reimbursement Scenario
8.6.2.3. Competitive Insights
8.6.2.4. Saudi Arabia Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.6.3. UAE
8.6.3.1. Key Country Dynamics
8.6.3.2. Regulatory Landscape/Reimbursement Scenario
8.6.3.3. Competitive Insights
8.6.3.4. UAE Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.6.4. South Africa
8.6.4.1. Key Country Dynamics
8.6.4.2. Regulatory Landscape/Reimbursement Scenario
8.6.4.3. Competitive Insights
8.6.4.4. South Africa Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Regulatory Landscape/Reimbursement Scenario
8.6.5.3. Competitive Insights
8.6.5.4. Kuwait Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.2. North America
8.2.1. North America Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Regulatory Landscape/Reimbursement Scenario
8.2.2.3. Competitive Insights
8.2.2.4. U.S. Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Regulatory Landscape/Reimbursement Scenario
8.2.3.3. Competitive Insights
8.2.3.4. Canada Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3. Europe
8.3.1. Europe Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.2. U.K.
8.3.2.1. Key Country Dynamics
8.3.2.2. Regulatory Landscape/Reimbursement Scenario
8.3.2.3. Competitive Insights
8.3.2.4. U.K. Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Regulatory Landscape/Reimbursement Scenario
8.3.3.3. Competitive Insights
8.3.3.4. Germany Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Regulatory Landscape/Reimbursement Scenario
8.3.4.3. Competitive Insights
8.3.4.4. France Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Regulatory Landscape/Reimbursement Scenario
8.3.5.3. Competitive Insights
8.3.5.4. Italy Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Regulatory Landscape/Reimbursement Scenario
8.3.6.3. Competitive Insights
8.3.6.4. Spain Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.7. Sweden
8.3.7.1. Key Country Dynamics
8.3.7.2. Regulatory Landscape/Reimbursement Scenario
8.3.7.3. Competitive Insights
8.3.7.4. Sweden Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.8. Denmark
8.3.8.1. Key Country Dynamics
8.3.8.2. Regulatory Landscape/Reimbursement Scenario
8.3.8.3. Competitive Insights
8.3.8.4. Denmark Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Regulatory Landscape/Reimbursement Scenario
8.3.9.3. Competitive Insights
8.3.9.4. Norway Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.2. China
8.4.2.1. Key Country Dynamics
8.4.2.2. Regulatory Landscape/Reimbursement Scenario
8.4.2.3. Competitive Insights
8.4.2.4. China Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.3. Japan
8.4.3.1. Key Country Dynamics
8.4.3.2. Regulatory Landscape/Reimbursement Scenario
8.4.3.3. Competitive Insights
8.4.3.4. Japan Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Regulatory Landscape/Reimbursement Scenario
8.4.4.3. Competitive Insights
8.4.4.4. India Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Regulatory Landscape/Reimbursement Scenario
8.4.5.3. Competitive Insights
8.4.5.4. South Korea Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Regulatory Landscape/Reimbursement Scenario
8.4.6.3. Competitive Insights
8.4.6.4. Australia Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Regulatory Landscape/Reimbursement Scenario
8.4.7.3. Competitive Insights
8.4.7.4. Thailand Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.5. Latin America
8.5.1. Latin America Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Regulatory Landscape/Reimbursement Scenario
8.5.2.3. Competitive Insights
8.5.2.4. Brazil Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Regulatory Landscape/Reimbursement Scenario
8.5.3.3. Competitive Insights
8.5.3.4. Mexico Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Regulatory Landscape/Reimbursement Scenario
8.5.4.3. Competitive Insights
8.5.4.4. Argentina Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.6.2. Saudi Arabia
8.6.2.1. Key Country Dynamics
8.6.2.2. Regulatory Landscape/Reimbursement Scenario
8.6.2.3. Competitive Insights
8.6.2.4. Saudi Arabia Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.6.3. UAE
8.6.3.1. Key Country Dynamics
8.6.3.2. Regulatory Landscape/Reimbursement Scenario
8.6.3.3. Competitive Insights
8.6.3.4. UAE Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.6.4. South Africa
8.6.4.1. Key Country Dynamics
8.6.4.2. Regulatory Landscape/Reimbursement Scenario
8.6.4.3. Competitive Insights
8.6.4.4. South Africa Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Regulatory Landscape/Reimbursement Scenario
8.6.5.3. Competitive Insights
8.6.5.4. Kuwait Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Market Share Analysis
9.4. Company Heat Map Analysis
9.5. Strategy Mapping
9.5.1. Expansion
9.5.2. Mergers & Acquisition
9.5.3. Partnerships & Collaborations
9.5.4. New Product Launches
9.5.5. Research And Development
9.6. Company Profiles
9.6.1. QIAGEN
9.6.1.1. Participant’s Overview
9.6.1.2. Financial Performance
9.6.1.3. Product Benchmarking
9.6.1.4. Recent Developments
9.6.2. BD
9.6.2.1. Participant’s Overview
9.6.2.2. Financial Performance
9.6.2.3. Product Benchmarking
9.6.2.4. Recent Developments
9.6.3. bioMérieux SA
9.6.3.1. Participant’s Overview
9.6.3.2. Financial Performance
9.6.3.3. Product Benchmarking
9.6.3.4. Recent Developments
9.6.4. F. Hoffmann-La Roche, Ltd.
9.6.4.1. Participant’s Overview
9.6.4.2. Financial Performance
9.6.4.3. Product Benchmarking
9.6.4.4. Recent Developments
9.6.5. Hologic, Inc. (Gen Probe)
9.6.5.1. Participant’s Overview
9.6.5.2. Financial Performance
9.6.5.3. Product Benchmarking
9.6.5.4. Recent Developments
9.6.6. Abbott
9.6.6.1. Participant’s Overview
9.6.6.2. Financial Performance
9.6.6.3. Product Benchmarking
9.6.6.4. Recent Developments
9.6.7. Quidel Corporation
9.6.7.1. Participant’s Overview
9.6.7.2. Financial Performance
9.6.7.3. Product Benchmarking
9.6.7.4. Recent Developments
9.6.8. Siemens Healthineers AG
9.6.8.1. Participant’s Overview
9.6.8.2. Financial Performance
9.6.8.3. Product Benchmarking
9.6.8.4. Recent Developments
9.6.9. Bio-Rad Laboratories, Inc.
9.6.9.1. Participant’s Overview
9.6.9.2. Financial Performance
9.6.9.3. Product Benchmarking
9.6.9.4. Recent Developments
9.6.10. Danaher
9.6.10.1. Participant’s Overview
9.6.10.2. Financial Performance
9.6.10.3. Product Benchmarking
9.6.10.4. Recent Developments
9.6.11. OraSure Technologies, Inc.
9.6.11.1. Participant’s Overview
9.6.11.2. Financial Performance
9.6.11.3. Product Benchmarking
9.6.11.4. Recent Developments
9.2. Company Categorization
9.3. Company Market Share Analysis
9.4. Company Heat Map Analysis
9.5. Strategy Mapping
9.5.1. Expansion
9.5.2. Mergers & Acquisition
9.5.3. Partnerships & Collaborations
9.5.4. New Product Launches
9.5.5. Research And Development
9.6. Company Profiles
9.6.1. QIAGEN
9.6.1.1. Participant’s Overview
9.6.1.2. Financial Performance
9.6.1.3. Product Benchmarking
9.6.1.4. Recent Developments
9.6.2. BD
9.6.2.1. Participant’s Overview
9.6.2.2. Financial Performance
9.6.2.3. Product Benchmarking
9.6.2.4. Recent Developments
9.6.3. bioMérieux SA
9.6.3.1. Participant’s Overview
9.6.3.2. Financial Performance
9.6.3.3. Product Benchmarking
9.6.3.4. Recent Developments
9.6.4. F. Hoffmann-La Roche, Ltd.
9.6.4.1. Participant’s Overview
9.6.4.2. Financial Performance
9.6.4.3. Product Benchmarking
9.6.4.4. Recent Developments
9.6.5. Hologic, Inc. (Gen Probe)
9.6.5.1. Participant’s Overview
9.6.5.2. Financial Performance
9.6.5.3. Product Benchmarking
9.6.5.4. Recent Developments
9.6.6. Abbott
9.6.6.1. Participant’s Overview
9.6.6.2. Financial Performance
9.6.6.3. Product Benchmarking
9.6.6.4. Recent Developments
9.6.7. Quidel Corporation
9.6.7.1. Participant’s Overview
9.6.7.2. Financial Performance
9.6.7.3. Product Benchmarking
9.6.7.4. Recent Developments
9.6.8. Siemens Healthineers AG
9.6.8.1. Participant’s Overview
9.6.8.2. Financial Performance
9.6.8.3. Product Benchmarking
9.6.8.4. Recent Developments
9.6.9. Bio-Rad Laboratories, Inc.
9.6.9.1. Participant’s Overview
9.6.9.2. Financial Performance
9.6.9.3. Product Benchmarking
9.6.9.4. Recent Developments
9.6.10. Danaher
9.6.10.1. Participant’s Overview
9.6.10.2. Financial Performance
9.6.10.3. Product Benchmarking
9.6.10.4. Recent Developments
9.6.11. OraSure Technologies, Inc.
9.6.11.1. Participant’s Overview
9.6.11.2. Financial Performance
9.6.11.3. Product Benchmarking
9.6.11.4. Recent Developments
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global IVD Infectious Diseases Market, By Region, 2018-2030 (USD Billion)
Table 5 Global IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 6 Global IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 7 Global IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 8 Global IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 9 North America IVD Infectious Diseases Market, By Country, 2018-2030 (USD Billion)
Table 10 North America IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 11 North America IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 12 North America IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 13 North America IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 14 U.S. IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 15 U.S. IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 16 U.S. IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 17 U.S. IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 18 Canada IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 19 Canada IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 20 Canada IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 21 Canada IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 22 Europe IVD Infectious Diseases Market, By Country, 2018-2030 (USD Billion)
Table 23 Europe IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 24 Europe IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 25 Europe IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 26 Europe IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 27 U.K. IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 28 U.K. IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 29 U.K. IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 30 U.K. IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 31 Germany IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 32 Germany America IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 33 Germany America IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 34 Germany America IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 35 France IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 36 France IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 37 France IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 38 France IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 39 Spain IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 40 Spain IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 41 Spain IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 42 Spain IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 43 Italy IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 44 Italy IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 45 Italy IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 46 Italy IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 47 Denmark IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 48 Denmark IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 49 Denmark IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 50 Denmark IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 51 Sweden IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 52 Sweden IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 53 Sweden IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 54 Sweden IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 55 Norway IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 56 Norway IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 57 Norway IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 58 Norway IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 59 Asia Pacific IVD Infectious Diseases Market, By Country, 2018-2030 (USD Billion)
Table 60 Asia Pacific IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 61 Asia Pacific IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 62 Asia Pacific IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 63 Asia Pacific IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 64 China IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 65 China IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 66 China IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 67 China IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 68 Japan IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 69 Japan IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 70 Japan IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 71 Japan IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 72 India IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 73 India IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 74 India IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 75 India IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 76 South Korea IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 77 South Korea IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 78 South Korea IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 79 South Korea IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 80 Thailand IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 81 Thailand IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 82 Thailand IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 83 Thailand IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 84 Australia IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 85 Australia IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 86 Australia IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 87 Australia IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 88 Latin America IVD Infectious Diseases Market, By Country, 2018-2030 (USD Billion)
Table 89 Latin America IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 90 Latin America IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 91 Latin America IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 92 Latin America IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 93 Brazil IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 94 Brazil IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 95 Brazil IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 96 Brazil IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 97 Mexico IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 98 Mexico IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 99 Mexico IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 100 Mexico IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 101 Argentina IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 102 Argentina IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 103 Argentina IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 104 Argentina IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 105 MEA IVD Infectious Diseases Market, By Country, 2018-2030 (USD Billion)
Table 106 MEA IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 107 MEA IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 108 MEA IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 109 MEA IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 110 South Africa IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 111 South Africa IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 112 South Africa IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 113 South Africa IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 114 UAE IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 115 UAE IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 116 UAE IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 117 UAE IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 118 Saudi Arabia IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 119 Saudi Arabia IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 120 Saudi Arabia IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 121 Saudi Arabia IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 122 Kuwait IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 123 Kuwait IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 124 Kuwait IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 125 Kuwait IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global IVD Infectious Diseases Market, By Region, 2018-2030 (USD Billion)
Table 5 Global IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 6 Global IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 7 Global IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 8 Global IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 9 North America IVD Infectious Diseases Market, By Country, 2018-2030 (USD Billion)
Table 10 North America IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 11 North America IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 12 North America IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 13 North America IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 14 U.S. IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 15 U.S. IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 16 U.S. IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 17 U.S. IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 18 Canada IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 19 Canada IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 20 Canada IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 21 Canada IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 22 Europe IVD Infectious Diseases Market, By Country, 2018-2030 (USD Billion)
Table 23 Europe IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 24 Europe IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 25 Europe IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 26 Europe IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 27 U.K. IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 28 U.K. IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 29 U.K. IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 30 U.K. IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 31 Germany IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 32 Germany America IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 33 Germany America IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 34 Germany America IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 35 France IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 36 France IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 37 France IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 38 France IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 39 Spain IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 40 Spain IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 41 Spain IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 42 Spain IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 43 Italy IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 44 Italy IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 45 Italy IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 46 Italy IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 47 Denmark IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 48 Denmark IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 49 Denmark IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 50 Denmark IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 51 Sweden IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 52 Sweden IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 53 Sweden IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 54 Sweden IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 55 Norway IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 56 Norway IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 57 Norway IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 58 Norway IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 59 Asia Pacific IVD Infectious Diseases Market, By Country, 2018-2030 (USD Billion)
Table 60 Asia Pacific IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 61 Asia Pacific IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 62 Asia Pacific IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 63 Asia Pacific IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 64 China IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 65 China IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 66 China IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 67 China IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 68 Japan IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 69 Japan IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 70 Japan IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 71 Japan IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 72 India IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 73 India IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 74 India IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 75 India IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 76 South Korea IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 77 South Korea IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 78 South Korea IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 79 South Korea IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 80 Thailand IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 81 Thailand IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 82 Thailand IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 83 Thailand IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 84 Australia IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 85 Australia IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 86 Australia IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 87 Australia IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 88 Latin America IVD Infectious Diseases Market, By Country, 2018-2030 (USD Billion)
Table 89 Latin America IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 90 Latin America IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 91 Latin America IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 92 Latin America IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 93 Brazil IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 94 Brazil IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 95 Brazil IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 96 Brazil IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 97 Mexico IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 98 Mexico IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 99 Mexico IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 100 Mexico IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 101 Argentina IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 102 Argentina IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 103 Argentina IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 104 Argentina IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 105 MEA IVD Infectious Diseases Market, By Country, 2018-2030 (USD Billion)
Table 106 MEA IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 107 MEA IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 108 MEA IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 109 MEA IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 110 South Africa IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 111 South Africa IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 112 South Africa IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 113 South Africa IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 114 UAE IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 115 UAE IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 116 UAE IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 117 UAE IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 118 Saudi Arabia IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 119 Saudi Arabia IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 120 Saudi Arabia IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 121 Saudi Arabia IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
Table 122 Kuwait IVD Infectious Diseases Market, By Product, 2018-2030 (USD Billion)
Table 123 Kuwait IVD Infectious Diseases Market, By Technology, 2018-2030 (USD Billion)
Table 124 Kuwait IVD Infectious Diseases Market, By Application, 2018-2030 (USD Billion)
Table 125 Kuwait IVD Infectious Diseases Market, By Test Location, 2018-2030 (USD Billion)
List of Figures
Figure 1 IVD infectious diseases market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Primary interviews in North America
Figure 6 Primary interviews in Europe
Figure 7 Primary interviews in Asia Pacific
Figure 8 Primary interviews in Middle East and Africa
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 IVD infectious disease market snapshot
Figure 14 Segment Insights
Figure 15 Strategy framework
Figure 16 Penetration & growth prospect mapping
Figure 17 Consumer behavior analysis
Figure 18 Factors influencing North America IVD infectious diseases market (%)
Figure 19 Factors influencing Europe IVD infectious diseases market (%)
Figure 20 Factors influencing Asia Pacific IVD infectious diseases market (%)
Figure 21 Factors influencing Latin America IVD infectious diseases market (%)
Figure 22 Factors influencing Middle East and Africa IVD infectious diseases market (%)
Figure 23 Market driver relevance analysis (Current & future impact)
Figure 24 Global population growth, by age-group, 2012-2022 (Million)
Figure 25 Global percentage of population, by age group, 2000 and 2050
Figure 26 General trend of CLIA-waived tests
Figure 27 Market restraint relevance analysis (Current & future impact)
Figure 28 Porter’s five forces analysis
Figure 29 PESTLE analysis
Figure 30 Strategy mapping
Figure 31 IVD infectious diseases market: Product movement analysis
Figure 32 Product segment dashboard
Figure 33 IVD infectious diseases market product outlook: Key takeaways
Figure 34 Instruments market estimates and forecast, 2018-2030 (USD Billion)
Figure 35 Reagents market estimates and forecast, 2018-2030 (USD Billion)
Figure 36 Software market estimates and forecast, 2018-2030 (USD Billion)
Figure 37 IVD infectious diseases market: Technology movement analysis
Figure 38 Technology segment dashboard
Figure 39 IVD infectious diseases market technology outlook: Key takeaways
Figure 40 Immunoassay market estimates and forecast, 2018-2030 (USD Billion)
Figure 41 Molecular diagnostics market estimates and forecast, 2018-2030 (USD Billion)
Figure 42 PCR market estimates and forecast, 2018-2030 (USD Billion)
Figure 43 In Situ Hybridization market estimates and forecast, 2018-2030 (USD Billion)
Figure 44 INAAT market estimates and forecast, 2018-2030 (USD Billion)
Figure 45 Chips and microarrays market estimates and forecast, 2018-2030 (USD Billion)
Figure 46 Sequencing & NGS market estimates and forecast, 2018-2030 (USD Billion)
Figure 47 TMA market estimates and forecast, 2018-2030 (USD Billion)
Figure 48 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 49 Microbiology market estimates and forecast, 2018-2030 (USD Billion)
Figure 50 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 51 IVD infectious diseases market: Technology movement analysis
Figure 52 Application segment dashboard
Figure 53 IVD infectious diseases market technology outlook: Key takeaways
Figure 54 MRSA market estimates and forecast, 2018-2030 (USD Billion)
Figure 55 Streptococcus market estimates and forecast, 2018-2030 (USD Billion)
Figure 56 Clostridium difficile market estimates and forecast, 2018-2030 (USD Billion)
Figure 57 VRE market estimates and forecast, 2018-2030 (USD Billion)
Figure 58 CRE market estimates and forecast, 2018-2030 (USD Billion)
Figure 59 Respiratory virus market estimates and forecast, 2018-2030 (USD Billion)
Figure 60 Candida market estimates and forecast, 2018-2030 (USD Billion)
Figure 61 TB & drug-resistant TB market estimates and forecast, 2018-2030 (USD Billion)
Figure 62 GI panel testing market estimates and forecast, 2018-2030 (USD Billion)
Figure 63 Chlamydia market estimates and forecast, 2018-2030 (USD Billion)
Figure 64 Gonorrhea market estimates and forecast, 2018-2030 (USD Billion)
Figure 65 HPV market estimates and forecast, 2018-2030 (USD Billion)
Figure 66 HIV market estimates and forecast, 2018-2030 (USD Billion)
Figure 67 Hepatitis C market estimates and forecast, 2018-2030 (USD Billion)
Figure 68 Hepatitis B market estimates and forecast, 2018-2030 (USD Billion)
Figure 69 COVID-19 market estimates and forecast, 2018-2030 (USD Billion)
Figure 70 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 71 IVD infectious diseases market: Test location movement analysis
Figure 72 Test location segment dashboard
Figure 73 IVD infectious diseases market test location outlook: Key takeaways
Figure 74 Point of Care market estimates and forecast, 2018-2030 (USD Billion)
Figure 75 Central laboratories market estimates and forecast, 2018-2030 (USD Billion)
Figure 76 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 77 Regional outlook, 2023 & 2030
Figure 78 Regional market dashboard
Figure 79 Regional marketplace: Key takeaways
Figure 80 North America market share and leading players, 2023
Figure 81 Europe market share and leading players, 2023
Figure 82 Asia Pacific market share and leading players, 2023
Figure 83 Latin America market share and leading players, 2023
Figure 84 Middle East and Africa market share and leading players, 2023
Figure 85 North America, SWOT
Figure 86 Europe, SWOT
Figure 87 Asia Pacific, SWOT
Figure 88 Latin America, SWOT
Figure 89 Middle East and Africa, SWOT
Figure 90 North America IVD infectious diseases market, 2018-2030 (USD Billion)
Figure 91 U.S. key country dynamics
Figure 92 U.S. IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 93 Canada key country dynamics
Figure 94 Canada IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 95 Europe IVD infectious diseases market, 2018-2030 (USD Billion)
Figure 96 UK key country dynamics
Figure 97 UK IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 98 Germany key country dynamics
Figure 99 Germany IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 100 Spain key country dynamics
Figure 101 Spain IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 102 France key country dynamics
Figure 103 France IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 104 Italy key country dynamics
Figure 105 Italy IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 106 Denmark key country dynamics
Figure 107 Denmark IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 108 Sweden key country dynamics
Figure 109 Sweden IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 110 Norway key country dynamics
Figure 111 Norway IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 112 Asia Pacific IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 113 Japan key country dynamics
Figure 114 Japan IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 115 China key country dynamics
Figure 116 China IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 117 India key country dynamics
Figure 118 India IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 119 South Korea key country dynamics
Figure 120 South Korea IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 121 Australia key country dynamics
Figure 122 Australia IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 123 Thailand key country dynamics
Figure 124 Thailand IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 125 Latin America IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 126 Brazil key country dynamics
Figure 127 Brazil IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 128 Mexico key country dynamics
Figure 129 Mexico IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 130 Argentina key country dynamics
Figure 131 Argentina IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 132 MEA IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 133 South Africa key country dynamics
Figure 134 South Africa IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 135 Saudi Arabia key country dynamics
Figure 136 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 137 UAE key country dynamics
Figure 138 UAE IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 139 Kuwait key country dynamics
Figure 140 Kuwait IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 141 Ansoff Matrix
Figure 142 Heat map analysis
Figure 143 Company market share analysis,2023
Figure 144 Company market position analysis
Figure 145 Market differentiators
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Primary interviews in North America
Figure 6 Primary interviews in Europe
Figure 7 Primary interviews in Asia Pacific
Figure 8 Primary interviews in Middle East and Africa
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 IVD infectious disease market snapshot
Figure 14 Segment Insights
Figure 15 Strategy framework
Figure 16 Penetration & growth prospect mapping
Figure 17 Consumer behavior analysis
Figure 18 Factors influencing North America IVD infectious diseases market (%)
Figure 19 Factors influencing Europe IVD infectious diseases market (%)
Figure 20 Factors influencing Asia Pacific IVD infectious diseases market (%)
Figure 21 Factors influencing Latin America IVD infectious diseases market (%)
Figure 22 Factors influencing Middle East and Africa IVD infectious diseases market (%)
Figure 23 Market driver relevance analysis (Current & future impact)
Figure 24 Global population growth, by age-group, 2012-2022 (Million)
Figure 25 Global percentage of population, by age group, 2000 and 2050
Figure 26 General trend of CLIA-waived tests
Figure 27 Market restraint relevance analysis (Current & future impact)
Figure 28 Porter’s five forces analysis
Figure 29 PESTLE analysis
Figure 30 Strategy mapping
Figure 31 IVD infectious diseases market: Product movement analysis
Figure 32 Product segment dashboard
Figure 33 IVD infectious diseases market product outlook: Key takeaways
Figure 34 Instruments market estimates and forecast, 2018-2030 (USD Billion)
Figure 35 Reagents market estimates and forecast, 2018-2030 (USD Billion)
Figure 36 Software market estimates and forecast, 2018-2030 (USD Billion)
Figure 37 IVD infectious diseases market: Technology movement analysis
Figure 38 Technology segment dashboard
Figure 39 IVD infectious diseases market technology outlook: Key takeaways
Figure 40 Immunoassay market estimates and forecast, 2018-2030 (USD Billion)
Figure 41 Molecular diagnostics market estimates and forecast, 2018-2030 (USD Billion)
Figure 42 PCR market estimates and forecast, 2018-2030 (USD Billion)
Figure 43 In Situ Hybridization market estimates and forecast, 2018-2030 (USD Billion)
Figure 44 INAAT market estimates and forecast, 2018-2030 (USD Billion)
Figure 45 Chips and microarrays market estimates and forecast, 2018-2030 (USD Billion)
Figure 46 Sequencing & NGS market estimates and forecast, 2018-2030 (USD Billion)
Figure 47 TMA market estimates and forecast, 2018-2030 (USD Billion)
Figure 48 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 49 Microbiology market estimates and forecast, 2018-2030 (USD Billion)
Figure 50 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 51 IVD infectious diseases market: Technology movement analysis
Figure 52 Application segment dashboard
Figure 53 IVD infectious diseases market technology outlook: Key takeaways
Figure 54 MRSA market estimates and forecast, 2018-2030 (USD Billion)
Figure 55 Streptococcus market estimates and forecast, 2018-2030 (USD Billion)
Figure 56 Clostridium difficile market estimates and forecast, 2018-2030 (USD Billion)
Figure 57 VRE market estimates and forecast, 2018-2030 (USD Billion)
Figure 58 CRE market estimates and forecast, 2018-2030 (USD Billion)
Figure 59 Respiratory virus market estimates and forecast, 2018-2030 (USD Billion)
Figure 60 Candida market estimates and forecast, 2018-2030 (USD Billion)
Figure 61 TB & drug-resistant TB market estimates and forecast, 2018-2030 (USD Billion)
Figure 62 GI panel testing market estimates and forecast, 2018-2030 (USD Billion)
Figure 63 Chlamydia market estimates and forecast, 2018-2030 (USD Billion)
Figure 64 Gonorrhea market estimates and forecast, 2018-2030 (USD Billion)
Figure 65 HPV market estimates and forecast, 2018-2030 (USD Billion)
Figure 66 HIV market estimates and forecast, 2018-2030 (USD Billion)
Figure 67 Hepatitis C market estimates and forecast, 2018-2030 (USD Billion)
Figure 68 Hepatitis B market estimates and forecast, 2018-2030 (USD Billion)
Figure 69 COVID-19 market estimates and forecast, 2018-2030 (USD Billion)
Figure 70 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 71 IVD infectious diseases market: Test location movement analysis
Figure 72 Test location segment dashboard
Figure 73 IVD infectious diseases market test location outlook: Key takeaways
Figure 74 Point of Care market estimates and forecast, 2018-2030 (USD Billion)
Figure 75 Central laboratories market estimates and forecast, 2018-2030 (USD Billion)
Figure 76 Others market estimates and forecast, 2018-2030 (USD Billion)
Figure 77 Regional outlook, 2023 & 2030
Figure 78 Regional market dashboard
Figure 79 Regional marketplace: Key takeaways
Figure 80 North America market share and leading players, 2023
Figure 81 Europe market share and leading players, 2023
Figure 82 Asia Pacific market share and leading players, 2023
Figure 83 Latin America market share and leading players, 2023
Figure 84 Middle East and Africa market share and leading players, 2023
Figure 85 North America, SWOT
Figure 86 Europe, SWOT
Figure 87 Asia Pacific, SWOT
Figure 88 Latin America, SWOT
Figure 89 Middle East and Africa, SWOT
Figure 90 North America IVD infectious diseases market, 2018-2030 (USD Billion)
Figure 91 U.S. key country dynamics
Figure 92 U.S. IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 93 Canada key country dynamics
Figure 94 Canada IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 95 Europe IVD infectious diseases market, 2018-2030 (USD Billion)
Figure 96 UK key country dynamics
Figure 97 UK IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 98 Germany key country dynamics
Figure 99 Germany IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 100 Spain key country dynamics
Figure 101 Spain IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 102 France key country dynamics
Figure 103 France IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 104 Italy key country dynamics
Figure 105 Italy IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 106 Denmark key country dynamics
Figure 107 Denmark IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 108 Sweden key country dynamics
Figure 109 Sweden IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 110 Norway key country dynamics
Figure 111 Norway IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 112 Asia Pacific IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 113 Japan key country dynamics
Figure 114 Japan IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 115 China key country dynamics
Figure 116 China IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 117 India key country dynamics
Figure 118 India IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 119 South Korea key country dynamics
Figure 120 South Korea IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 121 Australia key country dynamics
Figure 122 Australia IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 123 Thailand key country dynamics
Figure 124 Thailand IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 125 Latin America IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 126 Brazil key country dynamics
Figure 127 Brazil IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 128 Mexico key country dynamics
Figure 129 Mexico IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 130 Argentina key country dynamics
Figure 131 Argentina IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 132 MEA IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 133 South Africa key country dynamics
Figure 134 South Africa IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 135 Saudi Arabia key country dynamics
Figure 136 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 137 UAE key country dynamics
Figure 138 UAE IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 139 Kuwait key country dynamics
Figure 140 Kuwait IVD infectious diseases market estimates and forecast, 2018-2030 (USD Billion)
Figure 141 Ansoff Matrix
Figure 142 Heat map analysis
Figure 143 Company market share analysis,2023
Figure 144 Company market position analysis
Figure 145 Market differentiators
Companies Mentioned
- QIAGEN
- BD
- bioMérieux SA
- F. Hoffmann-La Roche, Ltd.
- Hologic, Inc. (Gen Probe)
- Abbott
- Quidel Corporation
- Siemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- Danaher
- OraSure Technologies, Inc.
Methodology
LOADING...
